Cytek Biosciences Inc (CTKB)
6.265
-0.12
(-1.96%)
USD |
NASDAQ |
May 08, 16:00
6.265
0.00 (0.00%)
After-Hours: 16:18
Cytek Biosciences Gross Profit Margin (Quarterly): 56.75% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 56.75% |
| September 30, 2023 | 56.62% |
| June 30, 2023 | 56.67% |
| March 31, 2023 | 56.72% |
| December 31, 2022 | 60.77% |
| September 30, 2022 | 66.36% |
| June 30, 2022 | 61.16% |
| March 31, 2022 | 57.54% |
| Date | Value |
|---|---|
| December 31, 2021 | 60.77% |
| September 30, 2021 | 61.89% |
| June 30, 2021 | 64.93% |
| March 31, 2021 | 59.68% |
| December 31, 2020 | 63.52% |
| September 30, 2020 | 62.23% |
| June 30, 2020 | 43.22% |
| March 31, 2020 | 46.56% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
43.22%
Minimum
Jun 2020
66.36%
Maximum
Sep 2022
58.46%
Average
60.23%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Ainos Inc | -559.7% |
| OpGen Inc | 1.01% |
| Zomedica Corp | 69.14% |
| LENSAR Inc | 42.54% |
| Eargo Inc (DELISTED) | 52.39% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -2.92% |
| Return on Assets | -2.35% |
| Return on Invested Capital | -2.90% |
| Profit Margin (Quarterly) | 9.45% |
| Operating Margin (Quarterly) | -0.24% |
| Return on Net Operating Assets | -4.73% |